SC481291 2.7.14 31.12.15 31.12.15 Company accounts Private Limited Company FY true false true false true false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC4812912014-07-01SC4812912015-12-31SC4812912014-07-022015-12-31SC4812912014-07-01SC481291ns12:Scotland2014-07-022015-12-31SC481291ns14:PoundSterling2014-07-022015-12-31SC481291ns7:Director12014-07-022015-12-31SC481291ns7:OrdinaryShareClass12014-07-022015-12-31SC481291ns7:Director22014-07-022015-12-31SC481291ns7:RegisteredOffice2014-07-022015-12-31SC481291ns7:OrdinaryShareClass12015-12-31
REGISTERED NUMBER: SC481291 (Scotland)















Abbreviated Unaudited Accounts

for the Period

2 July 2014 to 31 December 2015

for

Cryogenetics Technologies Uk Limited
Cryogenetics Technologies Uk Limited (Registered number: SC481291)






Contents of the Abbreviated Accounts
for the Period 2 July 2014 to 31 December 2015




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3
Cryogenetics Technologies Uk Limited

Company Information
for the Period 2 July 2014 to 31 December 2015







DIRECTORS: R R Ferguson
J Ulheim





REGISTERED OFFICE: Floor 1
24 Blythswood Square
Glasgow
G2 4BG





REGISTERED NUMBER: SC481291 (Scotland)





Cryogenetics Technologies Uk Limited (Registered number: SC481291)

Abbreviated Balance Sheet
31 December 2015

Notes £   
CURRENT ASSETS
Stocks 2,677
Debtors 35,545
Cash at bank 14,103
52,325
CREDITORS
Amounts falling due within one year (105,533 )
NET CURRENT LIABILITIES (53,208 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(53,208
)

CREDITORS
Amounts falling due after more than one year (20,000 )
NET LIABILITIES (73,208 )

CAPITAL AND RESERVES
Called up share capital 2 16,920
Profit and loss account (90,128 )
SHAREHOLDERS' FUNDS (73,208 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2015.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a) ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006
and
(b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395
and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 4 February 2016 and were signed on its behalf by:





R R Ferguson - Director

Cryogenetics Technologies Uk Limited (Registered number: SC481291)

Notes to the Abbreviated Accounts
for the Period 2 July 2014 to 31 December 2015

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared on the going concern basis of accounting. As at 31 December 2015 the
company had net liabilities of £73,208. The directors consider that the going concern basis of accounting is appropriate due
the continuing support of the company's shareholder.

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the Financial
Reporting Standard for Smaller Entities (effective April 2008).

Exemption from preparing a cash flow statement
Exemption has been taken from preparing a cash flow statement on the grounds that the company qualifies as a small
company.

Turnover
Turnover represents net invoiced sales for provision of fish reproduction storage services, technology and consultancy,
excluding value added tax. Invoices are recognised in the profit and loss account when the company obtains the right to
consideration and in line with the period to which they relate.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving
items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet
date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet
date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction.
Exchange differences are taken into account in arriving at the operating result.

2. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
16,920 Ordinary £1 16,920

16,920 Ordinary shares of £1 each were allotted and fully paid for cash at par during the period.

3. ULTIMATE PARENT COMPANY

Cryogenetics AS (incorporated in Norway ) is regarded by the directors as being the company's ultimate parent company.

Options

Monitor

  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
Monitor Now

Please Help Us!

Was this document useful to you? Please Like our page. The more Likes we get, the more documents we can supply you free. Thanks.